Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

SELL
$201.05 - $221.7 $8.05 Million - $8.87 Million
-40,028 Closed
0 $0
Q2 2023

Nov 13, 2023

BUY
$211.93 - $241.33 $4.27 Million - $4.86 Million
20,140 Added 101.27%
40,028 $9.66 Million
Q1 2023

Nov 13, 2023

SELL
$213.32 - $257.83 $11.4 Million - $13.7 Million
-53,269 Reduced 72.81%
19,888 $4.56 Million
Q1 2023

May 02, 2023

SELL
$213.32 - $257.83 $10.3 Million - $12.4 Million
-48,170 Reduced 65.84%
24,987 $5.73 Million
Q4 2022

Nov 13, 2023

BUY
$203.72 - $248.97 $9.81 Million - $12 Million
48,170 Added 192.78%
73,157 $17.2 Million
Q4 2022

Feb 10, 2023

BUY
$203.72 - $248.97 $14.9 Million - $18.2 Million
73,157 New
73,157 $17.2 Million
Q2 2021

Jul 26, 2021

BUY
$251.87 - $278.14 $230,461 - $254,498
915 New
915 $252,000

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $20.5B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Easterly Investment Partners LLC Portfolio

Follow Easterly Investment Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Easterly Investment Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Easterly Investment Partners LLC with notifications on news.